REPLOID Group Aktie 146541228 / AT0000A3HRX5
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
16.07.2026 10:27:24
|
EQS-Adhoc: REPLOID Group AG and PreZero plan joint insect processing and distribution company
|
EQS-Ad-hoc: REPLOID Group AG / Key word(s): Joint Venture REPLOID Group AG and PreZero plan joint insect processing and distribution company The Executive Board of REPLOID Group AG (“REPLOID”) today resolved to enter into a joint venture with PreZero Stiftung & Co. KG (“PreZero”) and is executing the corresponding agreements. In the new company, named “CIRCULAR ORGANICS REPLOID V+V GMBH & CO. KG,” PreZero will hold 51 percent and REPLOID 49 percent of the shares. Completion of the planned joint venture is subject to merger control clearance by the competent competition authorities. The joint company will be located at the Abfallwirtschaft Neckar-Odenwald (AWN) site in Buchen, Germany. The joint venture will procure live Black Soldier Fly larvae from both partners, process them into frozen protein slabs, and be responsible for the distribution of the final product. Each partner will contribute its specific strengths: PreZero will assume operational and administrative management of the company, while REPLOID will be responsible for research and development (R&D). Alternative proteins derived from the upcycling of organic residual materials represent a forward-looking growth market within the circular economy. With the establishment of the joint venture, the partners are combining their expertise in this specific segment. Both companies will continue to operate entirely independently in their respective core businesses.
Important Notice This announcement is a mandatory disclosure of inside information pursuant to Article 17 of the Market Abuse Regulation (EU) No 596/2014. It does not constitute financial analysis, advice or a recommendation regarding financial instruments, nor does it constitute an offer, solicitation, or invitation to buy or sell securities of REPLOID Group AG.
End of Inside Information
16-Jul-2026 CET/CEST News transmitted by EQS Group |
| Language: | English |
| Company: | REPLOID Group AG |
| Durisolstrasse 6 | |
| 4600 Wels | |
| Austria | |
| Phone: | +43 660 / 776 50 40 |
| E-mail: | office@reploid.eu |
| Internet: | reploid.eu |
| ISIN: | AT0000A3HRX5 |
| Listed: | Vienna Stock Exchange (Vienna MTF) |
| LEI Code: | 529900KNZ7JJ6VLDJL12 |
| EQS News ID: | 2366850 |
| End of Announcement | EQS News Service |
|
|
2366850 16-Jul-2026 CET/CEST
Trading Signals: Ferrari: Die zweite Chance
Ferrari hat nach einer schwierigen Zeit wieder auf die Überholspur gefunden. Starke Quartalszahlen, eine angehobene Jahresprognose und ein bis 2027 gefülltes Orderbuch sprechen für weiteren Rückenwind und bieten eine neue Trading Möglichkeit.
Weiterlesen!Nachrichten zu REPLOID Group AG Inhaber-Akt
|
27.07.26 |
EQS-News: REPLOID plant Übernahme eines Düngemittelwerks in Bayern (EQS Group) | |
|
27.07.26 |
EQS-News: REPLOID plans acquisition of fertilizer plant in Bavaria (EQS Group) | |
|
23.07.26 |
REPLOID expandiert: Vertriebsgesellschaft für Ozeanien gegründet (EQS Group) | |
|
23.07.26 |
REPLOID expands into Oceania with new sales company (EQS Group) | |
|
21.07.26 |
EQS-News: REPLOID has acquired a stake in Alimentastic with the option to obtain majority control (EQS Group) | |
|
21.07.26 |
EQS-News: REPLOID hat sich an Alimentastic beteiligt, mit der Option einer Mehrheitsübernahme (EQS Group) | |
|
17.07.26 |
EQS-News: REPLOID mit starker Ergebnisentwicklung 2023–2025 (EQS Group) | |
|
17.07.26 |
EQS-News: REPLOID reports strong earnings growth from 2023 to 2025 (EQS Group) |
Analysen zu REPLOID Group AG Inhaber-Akt
Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio
Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside ETF
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI nach neuem Rekord letztlich schwächer -- DAX beendet Handel nach Allzeithoch fester -- Asiens Börsen schliessen mehrheitlich tieferDer heimische Aktienmarkt zeigte sich am zweiten Handelstag der Woche unentschlossen. Der deutsche Aktienmarkt verbuchte unterdessen Gewinne. An der Wall Street sind rote Vorzeichen zu sehen. In Fernost zeigten sich daneben Verluste.


